Navigation Links
Accuray Announces Results for Fourth Quarter and Fiscal Year 2010

SUNNYVALE, Calif., Aug. 31 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the fourth quarter and fiscal year 2010, ended June 30, 2010.

For the fourth quarter of fiscal 2010, Accuray reported total revenue of $61.8 million, a 5.1 percent increase over the fourth quarter of fiscal 2009 total revenue of $58.8 million. For the fiscal year ended June 30, 2010, total revenue was $221.6 million, a twelve million dollar decrease from the $233.6 million in total revenue recorded for fiscal year 2009.

Net income for the fourth quarter of fiscal 2010 was $5.0 million, or $0.08 per diluted share, compared to net income of $1.2 million, or $0.02 per diluted share, during the same period last year. Net income for fiscal year 2010 was $2.8 million or $0.05 per diluted share, compared to net income of $609,000 or $0.01 per diluted share for fiscal year 2009.

During the fourth quarter of fiscal 2010, 16 CyberKnife® Robotic Radiosurgery Systems were added to company backlog, with a total value of $74 million. In addition, new service and other ancillary orders with a value of $18 million were signed.  During the fourth quarter, one order was canceled by a customer and removed from backlog.

Total backlog for the end of the fourth quarter of fiscal 2010 was $374 million, with approximately $132 million associated with CyberKnife System contracts and approximately $242 million associated with services and other recurring revenue.  

In the fourth quarter of fiscal 2010, 10 new CyberKnife Systems were installed, making a full year installation total of 31 systems. At the end of the 2010 fiscal year, the worldwide CyberKnife installation base was 206.

"With 16 CyberKnife orders added into backlog, we are pleased to report another strong quarter of continued sales momentum, which has yielded 56 net orders for fiscal 2010," said Euan Thomson, president and chief executive officer of Accuray Incorporated. "Cancer patients worldwide are receiving highly precise, non-invasive, state-of-the-art radiosurgery treatment from an expanding base of installed CyberKnife Systems."

Accuray's cash and investment balances at the end of the fourth quarter of 2010 totaled $145.3 million, which includes cash and cash equivalents of $45.4 million, restricted cash of $22,000 and short-term investments of $99.9 million. Not included in the year-end cash and investments balance was $5.9 million, net, of in-transit cash associated with the liquidation of our auction-rate securities on June 30, 2010, which was received on July 1, 2010.

Outlook The following statement is forward-looking and actual results may differ materially.  During fiscal year 2011 Accuray expects revenue to be in the range of $210 million to $225 million.

Additional InformationAdditional information regarding backlog segmentation, which will be discussed during the conference call, is available in the Investor Relations section of the company's Web site at

Earnings Call Open to Investors   Accuray will hold a conference call for financial analysts and investors on Tuesday, August 31, 2010 at 2:00 p.m. PT / 5:00 p.m. ET. The conference call dial-in numbers are 1-866-578-5771 (USA) or 1-617-213-8055 (International), Conference ID:  28021423.  A live webcast of the call will also be available from the Investor Relations section on the company's Web site at In addition, a recording of the call will be available by calling 1-888-286-8010 (USA) or 1-617-801-6888 (International), Conference ID number: 24002694, beginning at 5:00 p.m. PT / 8:00 p.m. ET, August 31, 2010 and will be available through September 3, 2010. A webcast replay will also be available from the Investor Relations section of the company's Web site at from approximately 5:00 p.m. PT / 8:00 p.m. ET today through Accuray's release of its results for the first quarter of fiscal 2011, ending September 30, 2010.  

About the CyberKnife® Robotic Radiosurgery SystemThe CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invasive head or body stabilization frames.

About AccurayAccuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 95,000 patients worldwide and currently more than 206 systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit

Safe Harbor StatementThis press release contains forward-looking statements, including those concerning Accuray's expectations about revenue for fiscal year 2011, the portion of revenue attributable to CyberKnife System revenue, gross margin, profitability, customer installation schedules, realization of backlog and service activity. Forward looking statements involve risks and uncertainties that may lead to actual results varying materially from the forward looking statements. Accordingly, investors are cautioned not to place undue reliance on such statements. Many factors could cause actual performance or results to differ materially from these forward looking statements, including, but not limited to the uncertainties associated with the medical device industry; variability of installation and sales cycle including customer financing and construction delays; changes in the regulatory environment, including reimbursement for CyberKnife procedures; market acceptance of products; and the impact of competition. These and other risks are discussed under the heading "Risk Factors" in our report on Form 10-K for the 2010 fiscal year which has been filed with the Securities and Exchange Commission. The Company assumes no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information. Accuray IncorporatedUnaudited Condensed Consolidated Statements of Operations(in thousands, except per share data)Three months endedYears endedJune 30, 2010June 27, 2009June 30, 2010June 27, 2009Net revenue:  Products

59,257Shared ownership program



2202409344,346Total net revenue

61,78858,803221,625233,598Cost of revenue:  Cost of products

18,55919,01065,19768,904Cost of shared ownership program

1421211,019775Cost of services

11,87312,37750,73244,591Cost of other

1562056594,038Total cost of revenue

30,73031,713117,607118,308Gross profit

31,05827,090104,018115,290Operating expenses:  Selling and marketing

8,2969,87034,18745,493Research and development

8,3739,18531,52335,992General and administrative

8,3937,71035,47236,223Total operating expenses

25,06226,765101,182117,708Income (loss) from operations

5,9963252,836(2,418)Interest and other income, net

(683)64613,082Income before provision for income taxes

5,3139712,837664Provision (benefit) for income taxes

292(251)(4)55Net income

9Net income per common share, basic and diluted:Basic


.01Weighted average common shares outstanding used in computing net income per
share:  Basic


60,56459,32460,19158,729Cost of revenue, selling and marketing, research and development, and general
and administrative expenses include stock-based compensation charges as follows:  Cost of revenue

2,285Selling and marketing

3,441Research and development

3,190General and administrative

,545Accuray IncorporatedUnaudited Condensed Consolidated Balance
Sheets(in thousands, except share amounts) June 30, June 27, 20102009Assets  Current assets:  Cash and cash equivalents

$  45,434$  36,835Restricted cash

22527Short-term marketable securities

99,88164,634Accounts receivable, net of allowance for doubtful accounts of $115at June 30, 2010 and $484 at June 27, 2009


28,18628,909Prepaid expenses and other current assets

19,3566,186Deferred cost of revenue—current

7,88918,984Total current assets

238,723192,502Long-term marketable securities

-57,252Property and equipment, net


4,4954,495Intangible assets, net

388668Deferred cost of revenue—noncurrent

3,2132,933Other assets

1,6811,470Total assets

$263,184$274,386Liabilities and stockholders' equity  Current liabilities:  Accounts payable

$  10,317$  14,941Accrued expenses

21,45516,188Customer advances—current

12,88413,185Deferred revenue—current

42,01968,105Total current liabilities

86,675112,419Long-term liabilities:  Long-term other liabilities

1,059288Customer advances—noncurrent

--Deferred revenue—noncurrent

5,3747,777Total liabilities

93,108120,484Stockholders' equity Preferred stock, $0.001 par value; authorized: 5,000,000 shares; no shares issuedand outstanding.

--Common stock, $0.001 par value; authorized: 100,000,000 shares; issued: 60,666,974
and 58,783,159 shares at June 30, 2010 and June 27, 2009, respectively; outstanding:
58,526,956 and 56,643,529 shares at June 30, 2010 and June 27, 2009, respectively.

5957Additional paid-in capital

287,764273,946Accumulated other comprehensive income (loss)

(71)416Accumulated deficit

(117,676)(120,517)Total stockholders' equity

170,076153,902Total liabilities and stockholders' equity

$263,184$274,386Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Euan Thomson, Ph.D


SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2010
2. Accuray Incorporated to Present at 20th Annual Oppenheimer Healthcare Conference
3. Accuray Ranked 155th Fastest Growing Company in North America on Deloittes 2009 Technology Fast 500(TM)
4. Accuray Announces Regionalized Management Strategy for Americas
5. Accurays Treatment Planning Service Active at 20 Percent of U.S. CyberKnife Centers
6. Accuray Introduces the CyberKnife(R) VSI(TM) System
7. Accuray Announces Results for Second Quarter Fiscal 2010
8. Accuray Incorporated to Report Financial Results for Second Quarter of Fiscal 2010
9. Accuray Hires General Manager for Japan
10. Accuray Incorporated to Present at 28th Annual J. P. Morgan Healthcare Conference
11. Accuray Incorporated to Present at Piper Jaffray Healthcare Conference and J. P. Morgan Small/Mid Cap Conference
Post Your Comments:
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/19/2017)... ZirMed Inc ., a recognized leader in cloud-based revenue cycle ... ranked #1 by its users for the seventh consecutive year ... ZirMed was recognized as the top-ranked end-to-end revenue cycle management ... 200 beds and holds one of the longest #1 ranking ... ...
(Date:9/12/2017)... Sept. 12, 2017   EcoVadis , the leading platform for environmental, ... first annual edition of its Global CSR Risk and Performance Index. The ... EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points across ... ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Global Healthcare ... scenic Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare ... activity. The fun run is geared towards children of all ages; it is ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
(Date:10/12/2017)... ... 12, 2017 , ... HMP , a leader in healthcare events and ... Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie ... annual award competition recognizes editorial and design excellence across a range of sectors. This ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United States, ... In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the ... have extremely low property-tax rates, which contributes to the relatively lower cost of ...
Breaking Medicine News(10 mins):